Natalie is a member of the life sciences patent team.
She has an undergraduate BSc degree in Molecular Biology and Biochemistry from Durham University and a PhD in Biochemistry from the University of Bath. During her undergraduate degree, Natalie spent 12 months at MedImmune (AstraZeneca) where her research project focused on increasing recombinant antibody expression in mammalian expression hosts. Her doctoral research investigated ubiquitin-dependent mechanisms in cell cycle regulation.
Natalie joined Mewburn Ellis LLP in 2019 from another London based patent attorney firm.